Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women

American Journal of Medicine

Volumn 114, Issue 7, 2003, Pages 599-602

  Hamelin, Bettina A ^a,c   Méthot, Julie ^a   Arsenault, Marie ^b,c   Pilote, Sylvie ^c   Poirier, Paul ^c   Plante, Sylvain ^c   Bogaty, Peter ^b,c  

^a Faculty of Pharmacy   (Canada)

^b Faculty of Medicine   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROGESTERONE; TESTOSTERONE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DATA ANALYSIS; DEMOGRAPHY; DISEASE COURSE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INFORMATION PROCESSING; MENARCHE; MENSTRUAL CYCLE; OVARY CYCLE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; UNSTABLE ANGINA PECTORIS;

EID: 0038325739     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00051-2     Document Type: Article

References (27)

1. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 111:1986;383-390.
2. Petitti D.B., Sidney S., Quesenberry C.P. Jr, Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke. 28:1997;280-283.
3. Gordon T., Kannel W.B., Hjortland M.C., McNamara P.M. Menopause and coronary heart disease. Ann Intern Med. 89:1978;157-161.
4. Stoney C.M., Owens J.F., Guzick D.S., Matthews K.A. A natural experiment on the effects of ovarian hormones on cardiovascular risk factors and stress reactivity: bilateral salpingo oophorectomy versus hysterectomy only. Health Psychol. 16:1997;349-358.
5. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 273:1995;199-208.
6. Grodstein F., Stampfer M.J., Manson J.E., et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 335:1996;453-461.
7. Bush T.L. Estrogen replacement and coronary artery disease: the evidence for primary and secondary prevention. J Clin Endocrinol Metab. 81:1996;3830-3832.
8. Grodstein F., Stampfer M.J., Colditz G.A., et al. Postmenopausal hormone therapy and mortality. N Engl J Med. 336:1997;1769-1775.
9. Herrington D.M., Reboussin D.M., Brosnihan K.B., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 343:2000;522-529.
10. Viscoli C.M., Brass L.M., Kernan W.N., et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 345:2001;1243-1249.
11. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
12. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
13. Collins P., Beale C.M., Rosano G.M.C. Oestrogen as a calcium channel blocker. Eur Heart J. 17:(suppl D):1996;27-31.
14. Collins P., Shay J., Jiang C., Moss J. Nitric oxide accounts for dose-dependent Estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 90:1994;1964-1968.
15. Collins P., Rosano G.M.C., Sarrel P.M., et al. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
16. Rosano G.M.C., Sarrel P.M., Poole-Wilson P.A., Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 342:1993;133-136.
17. Moran V.H., Leathard H.L., Coley J. Cardiovascular functioning during the menstrual cycle. Clin Physiol. 20:2000;496-504.
18. Cunningham FG, Gant NF, Leveno KJ, et al. The endometrium and decidua. Menstruation and pregnancy. In: Cunningham FG, Gant NF, Leveno KJ, et al., eds. Williams Obstetrics. New York, New York: McGraw-Hill; 2001:65-83.
19. Kawano H., Motoyama T., Ohgushi M., et al. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med. 135:2001;977-981.
20. The North American Menopause Society. Normal physiology. In: Menopause Core Curriculum Study Guide. 2nd ed. Cleveland, Ohio: North American Menopause Society; 2002:15-20.
21. Polderman K.H., Stehouwer C.D., van Kamp G.J., et al. Modulation of plasma endothelin levels by the menstrual cycle. Metabolism. 49:2000;648-650.
22. Webb C.M., Ghatei M.A., McNeill J.G., et al. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation. 102:2000;1617-1622.
23. Wilcox J.G., Hatch I.E., Gentzschein E., et al. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors. Fertil Steril. 67:1997;273-277.
24. Dubey R.K., Jackson E.K., Keller P.J., et al. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension. 37:2001;640-644.
25. Rosselli M., Imthurm B., Macas E., et al. Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated no release. Biochem Biophys Res Commun. 202:1994;1543-1552.
26. Kharitonov S.A., Logan-Sinclair R.B., Busset C.M., Shinebourne E.A. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J. 72:1994;243-245.
27. Lloyd G.W., Patel N.R., McGing E., et al. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart. 84:2000;189-192.